ST. LUKES REGIONAL MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $7.6M
- Transactions
- 1,583
- Companies
- 40
- Average per transaction
- $4,781
Who reported the payments
| Vertex | $979,787 |
| Eli Lilly | $779,518 |
| Novartis | $707,523 |
| Hoffmann-la Roche Limited | $698,348 |
| Amgen | $565,011 |
| Boston Scientific | $483,301 |
| AstraZeneca | $449,009 |
| Genentech, Inc. | $364,756 |
| Astrazeneca UK Limited | $275,841 |
| AbbVie | $230,701 |
| CSL Behring | $223,766 |
| Sanofi Pasteur Inc. | $216,200 |
| Merck | $151,454 |
| UCB SA | $143,842 |
| Jazz Pharmaceuticals Inc. | $142,375 |
| Pfizer | $82,793 |
| Biomarin Pharmaceutical Inc. | $75,084 |
| Ascendis Pharma Endocrinology Inc | $68,048 |
| E.r. Squibb & Sons, L.L.C. | $65,806 |
| Tandem Diabetes Care, Inc. | $63,350 |
| American Regent | $60,791 |
| Abbott | $60,423 |
| Boehringer Ingelheim | $53,459 |
| Medtronic | $48,300 |
| OPKO Pharmaceuticals, LLC | $47,231 |
| Stryker | $45,191 |
| Sanofi US Services Inc. | $41,717 |
| Carlsmed, Inc. | $37,556 |
| DJO, LLC | $30,000 |
| Janssen Research & Development, LLC | $29,667 |
| Coherus Oncology, Inc. | $29,575 |
| Gilead | $27,200 |
| Trice Medical, Inc. | $23,970 |
| Sumitomo Pharma America, Inc. | $20,904 |
| Daiichi Sankyo Inc. | $18,050 |
| Argenx US, Inc. | $17,273 |
| Diasorin Inc. | $16,650 |
| Med-el Corporation | $15,900 |
| Angiodynamics, Inc. | $15,500 |
| Array Biopharma Inc | $14,036 |